D. Sacerdoti

发表

Renal vasoconstriction in cirrhosis evaluated by duplex doppler ultrasonography

P. Angeli, A. Gatta, D. Sacerdoti, 1993, Hepatology.

Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints

E. Grisan, L. Punzi, A. Doria, 2017, Clinical Rheumatology.

Arachidonic acid metabolites and endothelial dysfunction of portal hypertension.

P. Pesce, D. Sacerdoti, M. Bolognesi, 2015, Prostaglandins & other lipid mediators.

Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats.

N. Abraham, M. Schwartzman, J. Mcgiff, 1989, Science.

Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy.

D. Catalucci, M. Mongillo, M. Sandri, 2014, The Journal of clinical investigation.

Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats

P. Pontisso, P. Angeli, A. Gatta, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics.

P. Angeli, P. Amodio, A. Gatta, 1995, Gastroenterology.

Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1997, Journal of hepatology.

Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance

P. Angeli, L. Caregaro, A. Gatta, 1990, European journal of clinical investigation.

Impaired response to angiotensin II in Type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium countertransport activity

P. Fioretto, G. Opocher, D. Sacerdoti, 1991, Diabetologia.

Interobserver and interquipment variability of echo‐doppler examination of the portal vein: Effect of a cooperative training program

G. Ferraioli, M. Zoli, L. Bolondi, 1995, Hepatology.

Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: Analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters

M. Rugge, L. Giacomelli, A. Gatta, 2007, Scandinavian journal of gastroenterology.

Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.

L. Bolondi, F. Piscaglia, F. Trevisani, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: relationships with splanchnic haemodynamics.

A. Gatta, L. Spadaro, D. Sacerdoti, 2004, Ultrasound in medicine & biology.

Splenic impedance indices: A useful method to monitor patients after liver transplantation?

P. Angeli, A. Gatta, G. Gerunda, 1998, Hepatology.

Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE.

P. Angeli, J. Mcgiff, A. Gatta, 1997, The Journal of clinical investigation.

Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis

P. Amodio, A. Gatta, C. Mazzaro, 1996, The Lancet.

Relationship between portal blood flow measured by image‐directed doppler ultrasonography and hepatic blood flow measured by indocyanine green constant infusion in patients with cirrhosis

A. Gatta, D. Sacerdoti, M. Bolognesi, 1995, Journal of clinical ultrasound : JCU.

Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis

P. Angeli, P. Amodio, A. Gatta, 1994, Hepatology.

Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide‐5‐mononitrate in cirrhotic patients.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

New abdominal collaterals at ultrasound: a clue of progression of portal hypertension.

M. Zoli, S. Gaiani, D. Magalotti, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Thrombosis of the portal venous system.

S. Gaiani, A. Gatta, D. Sacerdoti, 2007, Journal of ultrasound.

Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI)

A. Andriulli, P. Angeli, S. Basili, 2016 .

Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.

A. Andriulli, E. Grandone, P. Rebulla, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Characterization of a murine model of cardiorenal syndrome type 1 by high-resolution Doppler sonography

N. Abraham, P. Pesce, D. Sacerdoti, 2015, Journal of Ultrasound.

A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas

A. Vitale, F. Calabrese, D. Sacerdoti, 2019, Journal of Surgery.

Splenic Doppler impedance indices estimate splenic congestion in patients with right-sided or congestive heart failure.

S. Gaiani, A. Gatta, P. Pesce, 2012, Ultrasound in medicine & biology.

Role of Atrial Natriuretic Peptide in the Pathogenesis of Sodium Retention in IDDM With and Without Glomerular Hyperfiltration

A. Gatta, F. Mantero, P. Fioretto, 1992, Diabetes.

Effect of acute and chronic treatment of tin on blood pressure in spontaneously hypertensive rats.

N. Abraham, J. Mcgiff, B. Escalante, 1992, The Tohoku journal of experimental medicine.

Differential effects of partial hepatectomy on hepatic and renal heme and cytochrome P450 metabolism.

N. Abraham, M. Schwartzman, A. Goodman, 1988, The American journal of the medical sciences.

Renal cytochrome P-450-dependent metabolism of arachidonic acid in spontaneously hypertensive rats.

N. Abraham, M. Schwartzman, J. Mcgiff, 1988, Biochemical pharmacology.

Platelets in Non-alcoholic Fatty Liver Disease

M. Zoncapè, D. Sacerdoti, A. Dalbeni, 2022, Frontiers in Pharmacology.

Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes.

G. Crepaldi, A. Saller, A. Sfriso, 2002, European journal of endocrinology.

The Hemodynamic Abnormalities in Short-Term Insulin Deficiency: The Role of Prostaglandin Inhibition

A. Avogaro, A. Tiengo, R. Scognamiglio, 1996, Diabetes.

Development of NASH in Obese Mice is Confounded by Adipose Tissue Increase in Inflammatory NOV and Oxidative Stress

L. Rodella, G. Favero, R. Rezzani, 2018, International journal of hepatology.

Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells*

J. Falck, J. Mcgiff, K. Lerea, 2004, Journal of Biological Chemistry.

Renal cytochrome P-450-dependent metabolism of arachidonic acid in cirrhotic rats.

N. Abraham, M. Schwartzman, J. Mcgiff, 1991, Journal of hepatology.

Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction.

G. Chiesa, L. Manni, L. Monti, 2019, Cardiovascular research.

Increased EETs participate in peripheral endothelial dysfunction of cirrhosis.

S. Gaiani, A. Gatta, P. Pesce, 2012, Prostaglandins & other lipid mediators.

HO-1 Induction Improves The Type-1 Cardiorenal Syndrome in Mice With Impaired Angiotensin II–Induced Lymphocyte Activation

N. Abraham, Larisa V. Fedorova, A. Kappas, 2013, Hypertension.

Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells.

J. Falck, G. Li Volti, N. Abraham, 2005, Antioxidants & redox signaling.

Heme Oxygenase Induction Suppresses Hepatic Hepcidin and Rescues Ferroportin and Ferritin Expression in Obese Mice

S. Peterson, N. Puri, D. Sacerdoti, 2017, Journal of nutrition and metabolism.

Inhibition of epoxyeicosatrienoic acid production in rats with cirrhosis has beneficial effects on portal hypertension by reducing splanchnic vasodilation

P. Angeli, F. Zampieri, P. Pesce, 2016, Hepatology.

Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites

P. Pontisso, P. Angeli, S. Quarta, 2005, Gut.

Beyond scoring: a modern histological assessment of chronic hepatitis should include tissue angiogenesis

M. Rugge, L. Giacomelli, D. Sacerdoti, 2014, Gut.

Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis

A. Gatta, F. Zampieri, D. Sacerdoti, 2012, Scandinavian journal of gastroenterology.

CLINICAL TRIALS STUDY

Bolognesi, P. Angeli, P. Amodio, 2014 .

Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding.

P. Angeli, L. Caregaro, A. Gatta, 1989, The American journal of gastroenterology.

Interobserver and inter‐equipment variability of echo‐Doppler sonographic evaluation of the superior mesenteric artery.

G. Ferraioli, M. Zoli, L. Bolondi, 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Carbon Monoxide-Mediated Activation of Large-Conductance Calcium-Activated Potassium Channels Contributes to Mesenteric Vasodilatation in Cirrhotic Rats

P. Angeli, S. Quarta, A. Gatta, 2007, Journal of Pharmacology and Experimental Therapeutics.

THE HEME OXYGENASE/CARBON MONOXIDE SYSTEM IN HEPATOBILIARY PATHOPHYSIOLOGY

A. Gatta, D. Sacerdoti, 2002 .

Chronic CO levels has a beneficial effect on vascular relaxation in diabetes

M. Pascoli, L. Rodella, N. Abraham, 2006 .

Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: Pathophysiological and clinical implications

P. Angeli, L. Caregaro, A. Gatta, 1992, Hepatology.

Chronic Treatment With Tin Normalizes Blood Pressure in Spontaneously Hypertensive Rats

B. Escalante, M. Davidian, D. Sacerdoti, 1991, Hypertension.

Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout

A. Gatta, D. Sacerdoti, M. Bolognesi, 1985, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase.

N. Abraham, M. Schwartzman, J. Mcgiff, 2006, American journal of physiology. Heart and circulatory physiology.

Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3.

A. Angelini, P. Pontisso, E. Novo, 2019, Annals of hepatology.

Renal effects of nadolol in cirrhosis

L. Caregaro, A. Gatta, D. Sacerdoti, 2004, European Journal of Clinical Pharmacology.

Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation.

P. Angeli, A. Gatta, D. Sacerdoti, 1998, Japanese heart journal.

11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells.

J. Falck, N. Abraham, M. Schwartzman, 2007, Prostaglandins & other lipid mediators.

Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experience

A. Mantovani, D. Sacerdoti, A. Dalbeni, 2022, Journal of digestive diseases.

Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2.

A. Gatta, D. Sacerdoti, C. Merkel, 1986, Journal of hepatology.

Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin‐aldosterone system in humans

P. Angeli, L. Caregaro, A. Gatta, 1988, Clinical pharmacology and therapy.

Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats.

P. Pontisso, F. Zampieri, P. Pesce, 2015, Prostaglandins & other lipid mediators.

11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.

S. Gaiani, J. Mcgiff, A. Gatta, 2011, Prostaglandins & other lipid mediators.

Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity.

P. Angeli, M. Plebani, P. Amodio, 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: Prevalence and relationships with hemodynamic alterations detected with Doppler sonography().

A. Avogaro, S. Gaiani, S. Vigili de Kreutzenberg, 2009, Journal of ultrasound.

Chronic CO levels have [corrected] a beneficial effect on vascular relaxation in diabetes.

L. Rodella, N. Abraham, D. Sacerdoti, 2006, Biochemical and biophysical research communications.

Heme oxygenase overexpression attenuates glucose-mediated oxidative stress in quiescent cell phase: linking heme to hyperglycemia complications.

G. Li Volti, N. Abraham, G. Scapagnini, 2005, Current neurovascular research.

Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats.

S. Quarta, A. Gatta, F. Zampieri, 2011, Journal of hepatology.

Role of HO/CO in the Control of Peripheral Circulation in Humans

S. Gaiani, A. Gatta, P. Pesce, 2012, International journal of hypertension.

A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped‐care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients

P. Angeli, L. Caregaro, A. Gatta, 1991, Hepatology.

Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1987, Journal of hepatology.

Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics.

P. Angeli, A. Gatta, D. Sacerdoti, 1987, Clinical physiology.

Splenic Doppler impedance indices: Influence of different portal hemodynamic conditions

P. Angeli, A. Gatta, G. Gerunda, 1996, Hepatology.

Paraumbilical vein patency in cirrhosis: Effects on hepatic hemodynamics evaluated by doppler sonography

A. Gatta, D. Sacerdoti, M. Bolognesi, 1995, Hepatology.

Hemodynamic evaluation of the addition of isosorbide‐5‐mononitrate to nadolol in cirrhotic patients with insufficient response to the β‐ blocker alone

P. Angeli, A. Gatta, D. Sacerdoti, 1997, Hepatology.

Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1986, British journal of clinical pharmacology.

Left ventricular diastolic function in liver cirrhosis.

A. Desideri, P. Angeli, A. Gatta, 1996, Scandinavian journal of gastroenterology.

Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial.

P. Angeli, L. Caregaro, A. Gatta, 1991, Archives of internal medicine.

Novel renal arachidonate metabolites.

M. Schwartzman, J. Mcgiff, D. Sacerdoti, 1988, The American journal of the medical sciences.

Portal hypertension: state of the art.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1999, Italian journal of gastroenterology and hepatology.

Interobserver and arterial Doppler interequipment variability of hepatic, splenic, and renal resistance indices in normal subjects and patients with cirrhosis

M. Zoli, L. Bolondi, S. Gaiani, 1997 .

POSTER PRESENTATIONS

R. Motterlini, F. Calabrese, D. Sacerdoti, 2007 .

Central Nervous System Alterations in Liver Cirrhosis: The Role of Portal-Systemic Shunt and Portal Hypoperfusion

P. Amodio, F. Del Piccolo, A. Gatta, 2003, Metabolic Brain Disease.

Central Nervous System Alterations in Liver Cirrhosis: The Role of Portal-Systemic Shunt and Portal Hypoperfusion

P. Amodio, F. Del Piccolo, A. Gatta, 2004, Metabolic Brain Disease.

Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis

Enrico Grisan, Alessandro Coran, Roberto Stramare, 2015, Clinical Rheumatology.

Arterioportal fistulas in patients with liver cirrhosis: usefulness of color Doppler US for screening.

A. Gatta, D. Sacerdoti, M. Bolognesi, 2000, Radiology.

Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis

Paolo Angeli, P. Pontisso, P. Angeli, 2017, Journal of Vascular Research.

Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study

G. Corazza, A. Andriulli, F. Perticone, 2017, The American Journal of Gastroenterology.

Management of Severe Bleeding in Liver Disease and Transplantation

G. Biancofiore, M. Senzolo, D. Sacerdoti, 2016 .

ARTEROPORTAL FISTULAS BETWEEN THE ACCESSORY RIGHT HEPATIC, GASTRODUODENAL AND SUPERIOR MESENTERIC ARTERIES AND PORTAL VEIN: A DIFFICULT TECHNICAL PROBLEM TO OVERCOME IN LIVER TRANSPLANTATION

P. Angeli, D. Miotto, G. Gerunda, 2002, Transplantation.

Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins.

R. Trevisan, G. Viberti, P. Fioretto, 1990, Kidney international.

Heme oxygenase: the key to renal function regulation.

N. Abraham, G. Drummond, Xiaoying Li, 2009, American journal of physiology. Renal physiology.

Role of spleen enlargement in cirrhosis with portal hypertension.

A. Gatta, D. Sacerdoti, M. Bolognesi, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Comparison of fondaparinux and low molecular weight heparin in the treatment of portal vein thrombosis in cirrhosis.

P. Angeli, P. Simioni, M. Senzolo, 2021, The American journal of medicine.

Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1998, Journal of hepatology.

Clinical role of non-invasive assessment of portal hypertension.

D. Sacerdoti, M. Bolognesi, M. Di Pascoli, 2017, World journal of gastroenterology.

No association between the degree of liver steatosis and early signs of vasculopathy in T2DM.

S. Gaiani, P. Tessari, A. Coracina, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Covert hepatic encephalopathy: agreement and predictive validity of different indices.

P. Angeli, P. Amodio, A. Gatta, 2014, World journal of gastroenterology.

The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis

A. Gatta, D. Sacerdoti, M. Bolognesi, 2000, Hepatology.

Change in portal flow after liver transplantation: Effect on hepatic arterial resistance indices and role of spleen size

Angelo Gatta, Paolo Angeli, P. Angeli, 2002, Hepatology.

Renal vasoconstriction in cirrhosis

P. Angeli, A. Gatta, A. Colli, 1994, Hepatology.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.

Angelo Gatta, J. Mcgiff, A. Gatta, 2003, Prostaglandins & other lipid mediators.

Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.

A. Gatta, D. Sacerdoti, C. Merkel, 1984, American heart journal.

The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death

G. Marchesini, M. Zoli, A. Gatta, 1996, Hepatology.

The renal cytochrome P450 system generates novel arachidonic acid metabolites.

N. Abraham, M. Schwartzman, J. Mcgiff, 1989, Advances in experimental medicine and biology.

Hepatic arterial resistance indices in cirrhosis with and without portal vein thrombosis

D. Sacerdoti, 1993 .

Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking

D. Aprile, P. Angeli, P. Amodio, 2013, Metabolic Brain Disease.

Acute liver rejection: accuracy and predictive values of doppler US measurements--initial experience.

M. Rugge, P. Angeli, A. Gatta, 2005, Radiology.

Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index

M. Zoli, L. Bolondi, P. Angeli, 2000, American Journal of Gastroenterology.

Heme oxygenase-1 transduction in endothelial cells causes downregulation of monocyte chemoattractant protein-1 and of genes involved in inflammation and growth.

G. Li Volti, N. Abraham, G. Scapagnini, 2005, Cellular and molecular biology.

Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirrhosis.

M. Zoli, L. Bolondi, S. Gaiani, 1997, Journal of hepatology.

Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirhosis. J Hepatol 1997; 27: 986-992 (IF=4.974)

M. Zoli, L. Bolondi, S. Gaiani, 1997 .

EETs and HO-1 cross-talk.

P. Pesce, D. Sacerdoti, M. Bolognesi, 2016, Prostaglandins & other lipid mediators.

Natural heme oxygenase-1 inducers in hepatobiliary function.

G. Li Volti, F. Galvano, C. Di Giacomo, 2008, World journal of gastroenterology.

Long‐term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis

P. Amodio, A. Gatta, C. Mazzaro, 2000, Hepatology.

Changes in porto-hepatic hemodynamics during acute rejection (AR) in patients with liver transplant (OLT)

A. Gatta, D. Sacerdoti, M. Bolognesi, 2002 .

Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients.

P. Amodio, A. Gatta, D. Sacerdoti, 1992, Journal of hepatology.

Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices.

P. Angeli, A. Gatta, D. Sacerdoti, 1992, Gastroenterology.

Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis.

A. Gatta, D. Sacerdoti, C. Merkel, 1991, Journal of hepatology.

Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins.

A. Avogaro, A. Semplicini, A. Doria, 1990, The American journal of physiology.

Renal Haemodynamics in Essential Hypertension Assessed by 133-Xenon Washout and Selective Renal Angiography

A. Gatta, A. Pessina, D. Sacerdoti, 1982, Angiology.

Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler.

A. Gatta, D. Sacerdoti, M. Bolognesi, 2001, Ultrasound in medicine & biology.

Role of the Heme Oxygenases in Abnormalities of the Mesenteric Circulation in Cirrhotic Rats

N. Abraham, J. Mcgiff, A. Gatta, 2004, Journal of Pharmacology and Experimental Therapeutics.

Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation

M. Bolognesi, A. Gatta, D. Sacerdoti, 2005, Alimentary pharmacology & therapeutics.

Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia

D. Sacerdoti, A. Dalbeni, F. Cattazzo, 2023, Internal and Emergency Medicine.

The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study

E. Tacconelli, E. Carrara, M. Zoncapè, 2023, PloS one.

Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of italian patients with spinal-bulbar muscular atrophy

D. Sacerdoti, G. Querin, S. Mareso, 2018, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Gemfibrozil improves insulin sensitivity and flow‐mediated vasodilatation in type 2 diabetic patients

G. Pacini, A. Avogaro, A. Tiengo, 2001, European journal of clinical investigation.

Splanchnic impedance indices in portal hypertension

A. Favero, A. Gatta, D. Sacerdoti, 1998 .

Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients

M. Milella, A. Ruzzenente, M. Zoncapè, 2023, Cancers.

Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application

M. Bicego, E. Crisafulli, M. Zoncapè, 2023, Internal and Emergency Medicine.

Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates.

A. Morabito, P. Angeli, A. Gatta, 1998, Italian journal of gastroenterology and hepatology.

Interobserver and interquipment variability of echo‐doppler examination of the portal vein: Effect of a cooperative training program

G. Ferraioli, M. Zoli, L. Bolondi, 1995, Hepatology.

Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: Prevalence and relationships with hemodynamic alterations detected with Doppler sonography().

A. Avogaro, S. Gaiani, S. Vigili de Kreutzenberg, 2009, Journal of ultrasound.

Hepatitis C virus reinfection in liver transplant patients: Evaluation of liver damage progression with echo‐color doppler

M. Rugge, A. Gatta, D. Sacerdoti, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The Emerging Role of Heme Oxygenase and Its Metabolites in the Regulation of Cardiovascular Function

N. Abraham, D. Stec, D. Sacerdoti, 2012, International Journal of Hypertension.

obstruction of the p

P. Amodio, A. Gatta, D. Sacerdoti, 1997 .

SerpinB3 as hepatic marker of post-resective shear stress

P. Pontisso, F. Calabrese, D. Sacerdoti, 2023, Updates in Surgery.

Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.

M. Bolognesi, P. Angeli, P. Amodio, 1999, European journal of gastroenterology & hepatology.

Long-term effect of nadolol on quantitative liver function tests in patients with cirrhosis

L. Caregaro, A. Gatta, D. Sacerdoti, 2004, European Journal of Clinical Pharmacology.

Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis.

P. Angeli, A. Gatta, D. Sacerdoti, 1987 .

Renal vasoconstriction in cirrhosis evaluated by duplex doppler ultrasonography

P. Angeli, A. Gatta, D. Sacerdoti, 1993, Hepatology.

Clinical role of non-invasive assessment of portal hypertension.

D. Sacerdoti, M. Bolognesi, M. Di Pascoli, 2017, World journal of gastroenterology.

Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial.

P. Angeli, L. Caregaro, A. Gatta, 1987, Digestion.

Renal vasoconstriction in cirrhosis

P. Angeli, A. Gatta, A. Colli, 1994, Hepatology.

Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.

L. Caregaro, D. Sacerdoti, C. Merkel, 1987, Scandinavian journal of clinical and laboratory investigation.

Splenic Doppler impedance indices estimate splenic congestion in patients with right-sided or congestive heart failure.

S. Gaiani, A. Gatta, P. Pesce, 2012, Ultrasound in medicine & biology.